We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Baxter Contract-Manufacturing Plant Gets GMP Observations
Baxter has received good manufacturing practice (GMP)-related observations in a Form 483 for one of its large-volume parenteral drug manufacturing facilities.